Xerese (zuh-REES), a new Rx topical product for herpes simplex labialis

May 2011

You'll see ads for Xerese (zuh-REES), a new Rx topical product for herpes simplex labialis.

The company is even putting promotional signs near the OTC cold sore products in pharmacies.

Xerese is the first combo antiviral/anti-inflammatory drug for cold sores. It contains acyclovir 5% and hydrocortisone 1%.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Infectious Diseases GENERIC levofloxacin (Levaquin) beginning in June
Allergic Reactions true allergy to iodine is a medical myth
Cardiology how aggressively to treat cardiovascular risk factors in diabetes patients
Vaccines YOUNGER people are now candidates for Zostavax to prevent shingles
Antithrombotics whether patients should stop anticoagulant or antiplatelet meds before dental procedures
Antithrombotics Patients can now keep Pradaxa (dabigatran) for 60 days after the bottle is opened
Psychiatry systemic corticosteroids can cause adverse CNS effects
Oral Health Xerese (zuh-REES), a new Rx topical product for herpes simplex labialis
Women's Health when to use metformin or pioglitazone for polycystic ovary syndrome (PCOS)
Lupus lupus patients put on a new IV monoclonal antibody, Benlysta (ben-LIST-a, belimumab)
Neurology & Pain Abstral (AB-stral) will be the fourth immediate-release fentanyl
Asthma inhaled corticosteroids PRN for children with MILD persistent asthma